Details of the Drug Excipient

General Information of Drug Inactive Ingredient (DIG) (ID: E00487)

• DIG Name: Edetate calcium disodium
• Synonyms: 62-33-9; Edetate calcium disodium; Ethylenediaminetetraacetic acid calcium disodium salt; Adsorbonac; EDTA calcium disodium; Ethylenediaminetetraacetic Acid Disodium Calcium Salt; Calcium disodium ethylenediaminetetraacetate; Sodium calcium edetate; Calcium disodium EDTA; UNII-8U5D034955; Edetate Calcium Disodium (anhydrous); 23411-34-9; calcium;disodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate; Antallin; Calcitetracemate disodium; Calcium EDTA; Calcium disodium (ethylenedinitrilo)tetraacetate; Calcium disodium EDTA; Calcium disodium Versenate; NCGC00159485-02; 8U5D034955; Palmoxiricacid; Calcium disodium ethylenediamine tetraacetic acid; DSSTox_CID_16409; DSSTox_RID_79279; DSSTox_GSID_36409; Calcium sodium edetate hydrate; CHEBI:4757; C10H12N2O8.Ca.2Na; CHEMBL1200375; DTXSID2036409; Edetate calcium disodium anhydrous; BCP34403; Tox21_111709; ANW-41183; AKOS015902995; AKOS015914896; DB14598; CAS-62-33-9; Edetate calcium disodium anhydrous (USP); E385; I418; E0088; FT-0626320; D00571; Q-201095; Q9189390; Ethylensdiaminetetraacetic acid disodium calcium calcium salt; Sodium calcium edetate, European Pharmacopoeia (EP) Reference Standard; calcium disodium 2,2',2'',2'''-(ethane-1,2-diylbis(azanetriyl))tetraacetate; 100333-49-1; 74011-06-6; 7732-93-6; Sodium calcium edetate;EDTA calcium disodium;Ethylenediaminetetraacetic acid calcium disodium salt
• DIG Function: Complexing agent
• Formula: C10H12CaN2Na2O8
• Canonical SMILES: C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Ca+2]
• InChI: 1S/C10H16N2O8.Ca.2Na/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20;;;/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20);;;/q;+2;2*+1/p-4
• InChIKey: SHWNNYZBHZIQQV-UHFFFAOYSA-J
• Physicochemical Properties:
  Molecular Weight; 374.27; Topological Polar Surface Area; 167
  XlogP; N.A.; Complexity; 293
  Heavy Atom Count; 23; Rotatable Bond Count; 7
  Hydrogen Bond Donor Count; 0; Hydrogen Bond Acceptor Count; 10

Full List of Drug(s) Co-administrated with This DIG

17 Approved Drug(s) Co-administrated with This DIG

Drug Name	Drug ID	Indication	Formulation Name	Formulation ID
Acetaminophen	DMUIE76	Allergic rhinitis [CA08.0]	Acetaminophen 500 mg tablet	F00390
Ceftibuten	DMWV2AG	Acute otitis media [AB00]	Ceftibuten 400 mg capsule	F03680
Chlordiazepoxide	DMTN5XI	Alcohol withdrawal []	Chlordiazepoxide 10 mg capsule	F03981
crisaborole	DMNVKU6	Atopic dermatitis [EA80]	Crisaborole 2% ointment	F24258
Diphenhydramine	DMKQTBA	Hyperemesis gravidarum []	Diphenhydramine 25 mg capsule	F06256
Fluoxetine	DM3PD2C	Bipolar depression []	Fluoxetine 20 mg capsule	F08473
Fluvastatin	DM4MDJY	Arteriosclerosis [BD40]	Fluvastatin 20 mg capsule	F08582
Hydroxyurea	DMOQVU9	Chronic myelogenous leukaemia [2A20.0]	Hydroxyurea 500 mg capsule	F09899
Loxapine	DM8AI9U	Bipolar disorder [6A60]	Loxapine 10 mg capsule	F12660
Methylnaltrexone bromide	DMZTGN2	Opioid-induced constipation [DB32.1]	Methylnaltrexone Bromide 150mg tablet	F23817
Nortriptyline	DM4KDYJ	Depression [6A70-6A7Z]	Nortriptyline 10 mg capsule	F15511
Oxazepam	DMXNZM4	Alcohol withdrawal delirium []	Oxazepam 10 mg capsule	F16094
Phenytoin	DMNOKBV	Epilepsy [8A60-8A68]	Phenytoin 100 mg capsule	F17220
Tavaborole	DM3ED1A	Onychomycosis [EE12.1]	Tavaborole 5% solution	F23298
Temazepam	DM02A65	Insomnia [7A00-7A0Z]	Temazepam 15 mg capsule	F20761
Tetracycline	DMZA017	Acne vulgaris [ED80]	Tetracycline 250 mg capsule	F21016
Trimipramine	DM1SC8M	Major depressive disorder [6A70.3]	Trimipramine 50 mg capsule	F21721